keyword
MENU ▼
Read by QxMD icon Read
search

Atomoxetine

keyword
https://www.readbyqxmd.com/read/29664059/excessive-daytime-sleepiness-in-parkinson-s-disease-clinical-implications-and-management
#1
REVIEW
Yun Shen, Jun-Ying Huang, Jie Li, Chun-Feng Liu
Objective: Excessive daytime sleepiness (EDS) is one of the most common sleep abnormalities in patients with Parkinson's disease (PD), yet its multifactorial etiology complicates its treatment. This review summarized recent studies on the epidemiology, etiology, clinical implications, associated features, and evaluation of EDS in PD. The efficacy of pharmacologic and non-pharmacologic treatments for EDS in PD was also reviewed. Data Sources: English language articles indexed in PubMed and Cochrane databases and Chinese-language papers indexed in Wanfang and National Knowledge Infrastructure databases that were published between January 1987 and November 2017 were located using the following search terms: "sleepiness", "sleep and Parkinson's disease", and "Parkinson's disease and treatment"...
April 20, 2018: Chinese Medical Journal
https://www.readbyqxmd.com/read/29657744/studying-the-association-complex-formation-of-atomoxetine-and-fluvoxamine-with-eosin-y-and-its-application-in-their-fluorimetric-determination
#2
Sayed M Derayea, Mahmoud A Omar, Ahmed A Abu-Hassan
A simple, sensitive and non-extractive spectrofluorimetric method has been developed and validated for the determination of two psychoanaleptic drugs, atomoxetine and fluvoxamine, in pure forms and pharmaceutical dosage forms. The proposed method is based on the formation of binary complexes between eosin Y and the studied drugs in the presence of a Teorell-Stenhagen buffer. The quenching of the native fluorescence of eosin Y due to complex formation with the studied drugs was measured spectrofluorimetrically at 545 nm after excitation at 302 nm...
March 2018: Royal Society Open Science
https://www.readbyqxmd.com/read/29625537/evaluation-of-dystonia-in-children-and-adolescents-treated-with-atomoxetine-within-the-truven-marketscan-database-a-retrospective-cohort-study
#3
Kristin J Meyers, Himanshu P Upadhyaya, Robert Goodloe, Ludmila A Kryzhanovskaya, Marie A Liles-Burden, Nicole A Kellier-Steele, Michele Mancini
OBJECTIVE: Atomoxetine is a non-stimulant drug indicated for the treatment of attention-deficit/hyperactivity disorder in children aged ≥6 years, adolescents, and adults. In this retrospective cohort study, the incidence and risk of dystonia in children and adolescents treated with atomoxetine was compared to a propensity score-matched cohort of stimulant users. METHODS: Data between 01 January 2006 and 31 December 2014 from patients aged 6-17 years in the Truven Health Analytics MarketScan database were used to generate two cohorts of patients: (1) atomoxetine users and (2) stimulant (methylphenidates or amphetamines) users...
April 6, 2018: Expert Opinion on Drug Safety
https://www.readbyqxmd.com/read/29608930/atomoxetine-a-selective-norepinephrine-reuptake-inhibitor-improves-short-term-histological-outcomes-after-hypoxic-ischemic-brain-injury-in-the-neonatal-male-rat
#4
Masatake Toshimitsu, Yoshimasa Kamei, Mari Ichinose, Takahiro Seyama, Shinya Imada, Takayuki Iriyama, Tomoyuki Fujii
BACKGROUND: Despite the recent progress of perinatal medicine, perinatal hypoxic-ischemic (HI) insult remains an important cause of brain injury in neonates, and is pathologically characterized by neuronal loss and the presence of microglia. Neurotransmitters, such as norepinephrine (NE) and glutamate, are involved in the pathogenesis of hypoxic-ischemic encephalopathy via the interaction between neurons and microglia. Although it is well known that the monoamine neurotransmitter NE acts as an anti-inflammatory agent in the brain under pathological conditions, its effects on perinatal HI insult remains elusive...
March 30, 2018: International Journal of Developmental Neuroscience
https://www.readbyqxmd.com/read/29581452/semi-automated-biomarker-discovery-from-pharmacodynamic-effects-on-eeg-in-adhd-rodent-models
#5
Tatsuya Yokota, Zbigniew R Struzik, Peter Jurica, Masahito Horiuchi, Shuichi Hiroyama, Junhua Li, Yuji Takahara, Koichi Ogawa, Kohei Nishitomi, Minoru Hasegawa, Andrzej Cichocki
We propose a novel semi-automatic approach to design biomarkers for capturing pharmacodynamic effects induced by pharmacological agents on the spectral power of electroencephalography (EEG) recordings. We apply this methodology to investigate the pharmacodynamic effects of methylphenidate (MPH) and atomoxetine (ATX) on attention deficit/hyperactivity disorder (ADHD), using rodent models. We inject the two agents into the spontaneously hypertensive rat (SHR) model of ADHD, the Wistar-Kyoto rat (WKY), and the Wistar rat (WIS), and record their EEG patterns...
March 26, 2018: Scientific Reports
https://www.readbyqxmd.com/read/29573648/atomoxetine-for-amphetamine-type-stimulant-dependence-during-buprenorphine-treatment-a-randomized-controlled-trial
#6
Richard S Schottenfeld, Marek C Chawarski, Mehmet Sofuoglu, Weng-Tink Chooi, Norzarina M Zaharim, M Azhar M Yasin, Imran Ahmad, Sharifah Zubaidiah Syed Jaapar, B Kasinather Vicknasingam
BACKGROUND: Amphetamine type stimulants (ATS) use is highly prevalent and frequently co-occurs with opioid dependence in Malaysia and Asian countries. No medications have established efficacy for treating ATS use disorder. This study evaluated the safety, tolerability, and potential efficacy of atomoxetine for treating ATS use disorder. METHODS: Participants with opioid and ATS dependence (N = 69) were enrolled in a pilot, double-blind, placebo-controlled randomized clinical trial; all received buprenorphine/naloxone and behavioral counseling and were randomized to atomoxetine 80 mg daily (n = 33) or placebo (n = 33)...
March 10, 2018: Drug and Alcohol Dependence
https://www.readbyqxmd.com/read/29569329/evaluating-the-effectiveness-of-atomoxetine-for-the-treatment-of-primary-orthostatic-hypotension-in-adults
#7
Hetal Patel, Ashley Simpson, Gabrielle Palevoda, Genevieve M Hale
No abstract text is available yet for this article.
March 22, 2018: Journal of Clinical Hypertension
https://www.readbyqxmd.com/read/29533364/atomoxetine-in-the-treatment-of-adolescent-with-trichotillomania-and-attention-deficit-hyperactivity-disorder
#8
Serhat Türkoğlu, Fatih Hilmi Çetin
No abstract text is available yet for this article.
March 2018: Clinical Neuropharmacology
https://www.readbyqxmd.com/read/29510390/international-consensus-statement-on-screening-diagnosis-and-treatment-of-substance-use-disorder-patients-with-comorbid-attention-deficit-hyperactivity-disorder
#9
Cleo L Crunelle, Wim van den Brink, Franz Moggi, Maija Konstenius, Johan Franck, Frances R Levin, Geurt van de Glind, Zsolt Demetrovics, Corné Coetzee, Mathias Luderer, Arnt Schellekens, Frieda Matthys
Adult attention deficit/hyperactivity disorder (ADHD) often co-occurs with substance use disorders (SUD) and is associated with early onset and more severe development of SUD and with reduced treatment effectiveness. Screening tools allow for a good recognition of possible ADHD in adults with SUD and should be used routinely, followed by an ADHD diagnostic process initiated as soon as possible. Simultaneous and integrated treatment of ADHD and SUD, using a combination of pharmaco- and psychotherapy, is recommended...
2018: European Addiction Research
https://www.readbyqxmd.com/read/29505179/adverse-gestational-outcomes-associated-with-attention-deficit-hyperactivity-disorder-medication-exposure-during-pregnancy
#10
Chittaranjan Andrade
The use of attention-deficit/hyperactivity disorder (ADHD) medications during pregnancy has increased in recent years. An earlier article in this column examined whether psychostimulant medications, used to treated ADHD and related disorders, increase the risk of major congenital malformations in pregnancies with first trimester exposure to these drugs. This article examines whether amphetamines, methylphenidate, and atomoxetine exposure during early and late pregnancy are associated with other adverse gestational outcomes...
January 2018: Journal of Clinical Psychiatry
https://www.readbyqxmd.com/read/29504733/qtc-prolongation-after-adhd-medication
#11
(no author information available yet)
OBJECTIVE: Multicenter studies have shown that cardiovascular risks of ADHD medication are extremely low. However, QTc length has been shown to be increased in smaller samples of patients or case reports after stimulant and atomoxetine medication. Based on recent studies of genetic polymorphisms associated with drug-induced QTc prolongation and polymorphisms linkage to regional populations, we hypothesized that the drug-induced QTc prolongation could be a factor of particular polymorphisms linked to specific regional populations undistinguished in multicenter studies...
February 5, 2018: Neuro Endocrinology Letters
https://www.readbyqxmd.com/read/29503545/treatment-patterns-health-care-resource-utilization-and-costs-in-japanese-adults-with-attention-deficit-hyperactivity-disorder-treated-with-atomoxetine
#12
Hideyuki Imagawa, Saurabh P Nagar, William Montgomery, Tomomi Nakamura, Masayo Sato, Keith L Davis
Objective: To describe the characteristics and medication treatment patterns of adult patients with attention-deficit/hyperactivity disorder (ADHD) prescribed atomoxetine in Japan. Materials and methods: A retrospective analysis of insurance claims data was conducted using the Japan Medical Data Center database. Adults (≥18 years) with ADHD who had ≥1 atomoxetine claim from January 1, 2013 to December 31, 2014, and ≥180 to ≤900 days of follow-up were included...
2018: Neuropsychiatric Disease and Treatment
https://www.readbyqxmd.com/read/29501070/risk-of-suicide-attempts-in-adolescents-and-young-adults-with-attention-deficit-hyperactivity-disorder-a-nationwide-longitudinal-study
#13
Kai-Lin Huang, Han-Ting Wei, Ju-Wei Hsu, Ya-Mei Bai, Tung-Ping Su, Cheng-Ta Li, Wei-Chen Lin, Shih-Jen Tsai, Wen-Han Chang, Tzeng-Ji Chen, Mu-Hong Chen
BACKGROUND: Attention-deficit hyperactivity disorder (ADHD) increases the risk of suicidal behaviours through psychiatric comorbidities; however, a significant direct association has not been observed between ADHD and suicide attempts. Aims To evaluate the risk of suicide attempt in adolescents and young adults with ADHD. METHOD: Using a nationwide, population-based insurance claims database, this longitudinal cohort study enrolled 20 574 adolescents and young adults with ADHD and 61 722 age- and gender-matched controls between 2001 and 2009...
April 2018: British Journal of Psychiatry: the Journal of Mental Science
https://www.readbyqxmd.com/read/29489073/cannabis-withdrawal-in-adults-with-attention-deficit-hyperactivity-disorder
#14
Emeline Chauchard, Karen J Hartwell, Aimee L McRae-Clark, Brian J Sherman, David A Gorelick
Objective: Cannabis withdrawal has not been studied in adults with attention-deficit/hyperactivity disorder (ADHD) who have high rates of cannabis use. We aimed to describe cannabis withdrawal, motivations to quit, and strategies to quit cannabis use in cannabis-dependent adults with ADHD. Methods: Twenty-three adults with ADHD enrolled in a controlled clinical trial of pharmacotherapy (atomoxetine) for cannabis dependence (DSM-IV criteria) completed the Marijuana Quit Questionnaire (MJQQ) to provide information on their "most serious" quit attempt made without formal treatment...
February 22, 2018: Primary Care Companion to CNS Disorders
https://www.readbyqxmd.com/read/29476896/systemic-administration-of-guanfacine-improves-food-motivated-impulsive-choice-behavior-primarily-via-direct-stimulation-of-postsynaptic-%C3%AE-2a-adrenergic-receptors-in-rats
#15
Kouhei Nishitomi, Koji Yano, Mika Kobayashi, Kohei Jino, Takuya Kano, Naotaka Horiguchi, Shunji Shinohara, Minoru Hasegawa
Impulsive choice behavior, which can be assessed using the delay discounting task, is a characteristic of various psychiatric disorders, including attention-deficit/hyperactivity disorder (ADHD). Guanfacine is a selective α2A -adrenergic receptor agonist that is clinically effective in treating ADHD. However, there is no clear evidence that systemic guanfacine administration reduces impulsive choice behavior in the delay discounting task in rats. In the present study, we examined the effect of systemic guanfacine administration on food-motivated impulsive choice behavior in rats and the neuronal mechanism underlying this effect...
June 1, 2018: Behavioural Brain Research
https://www.readbyqxmd.com/read/29468526/attention-deficit-hyperactivity-disorder-pharmacotherapy-in-slovenian-adults-a-population-based-study
#16
Matej Stuhec, Igor Locatelli
Background Pharmacotherapy is the first line treatment for adult attention deficit hyperactivity disorder (ADHD) and the percentage of treated patients may indicate the quality of treatment of adult ADHD. The main aim of this study was to investigate the rates of pharmacological treatment for adult ADHD in Slovenia from 2003 to 2015. Methods The number of prescriptions per patient was obtained for three different age groups (18-24, 25-49, 50 + age group). The national consumption rates were obtained from the national database...
February 21, 2018: International Journal of Clinical Pharmacy
https://www.readbyqxmd.com/read/29460165/efficacy-and-safety-of-drugs-for-attention-deficit-hyperactivity-disorder-in-children-and-adolescents-a-network-meta-analysis
#17
Sarah C O S Padilha, Suzane Virtuoso, Fernanda S Tonin, Helena H L Borba, Roberto Pontarolo
The aim of this study is to gather evidence of head-to-head double-blind randomized-controlled trials on the efficacy and safety of available treatments for attention deficit hyperactivity disorder (ADHD) in children and adolescents. A systematic review was conducted by two independent reviewers in ten electronic databases (PROSPERO register CRD42016043239). Methodological quality of included studies was evaluated according to the Jadad scale. Network meta-analyses were performed including double-blinded head-to-head trials comparing active allopathic drugs in patients (0-18 years old) diagnosed with ADHD...
February 19, 2018: European Child & Adolescent Psychiatry
https://www.readbyqxmd.com/read/29456930/review-of-the-evidence-for-the-management-of-co-morbid-tic-disorders-in-children-and-adolescents-with-attention-deficit-hyperactivity-disorder
#18
REVIEW
Michael O Ogundele, Hani F Ayyash
Attention deficit hyperactivity disorder (ADHD) is the most common neurodevelopmental disorder in children and adolescents, with prevalence ranging between 5% and 12% in the developed countries. Tic disorders (TD) are common co-morbidities in paediatric ADHD patients with or without pharmacotherapy treatment. There has been conflicting evidence of the role of psychostimulants in either precipitating or exacerbating TDs in ADHD patients. We carried out a literature review relating to the management of TDs in children and adolescents with ADHD through a comprehensive search of MEDLINE, EMBASE, CINAHL and Cochrane databases...
February 8, 2018: World Journal of Clinical Pediatrics
https://www.readbyqxmd.com/read/29411149/pharmacological-treatment-of-attention-deficit-hyperactivity-disorder-during-pregnancy-and-lactation
#19
REVIEW
Asher Ornoy
INTRODUCTION: Attention deficit/hyperactivity disorder (ADHD) is a neurobehavioral problem found in 2-5% of adults. Stimulants and drugs that affect the dopaminergic, noradrenergic and/or serotonergic systems are effective treatment and are increasingly prescribed to women at child bearing age. It is consequently important that reliable information on the safety of these drugs in pregnancy is available so that appropriate therapeutic choices can be made. RESULTS: The data on stimulants (methylphenidate and amphetamines) are generally showing that there is no increase in the rate of major congenital anomalies...
February 6, 2018: Pharmaceutical Research
https://www.readbyqxmd.com/read/29404031/multi-spectroscopic-characterization-of-bovine-serum-albumin-upon-interaction-with-atomoxetine
#20
Arunkumar T Buddanavar, Sharanappa T Nandibewoor
The quenching interaction of atomoxetine (ATX) with bovine serum albumin (BSA) was studied in vitro under optimal physiological condition (pH=7.4) by multi-spectroscopic techniques. The mechanism of ATX-BSA system was a dynamic quenching process and was confirmed by the fluorescence spectra and lifetime measurements. The number of binding sites, binding constants and other binding characteristics were computed. Thermodynamic parameters ∆H° and ∆S° indicated that intermolecular hydrophobic forces predominantly stabilized the drug-protein system...
June 2017: Journal of Pharmaceutical Analysis
keyword
keyword
4829
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"